SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review

References

• Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018. doi:10.1001/jamaneurol.2020.206532469387
   PubMed Web of Science ®Google Scholar
• Koralnik IJ, Tyler KL. COVID −19: a global threat to the nervous system. Ann Neurol. 2020;88:1–11. doi:10.1002/ana.2580732506549
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020. doi:10.1016/j.bbi.2020.03.031
   Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683. doi:10.1001/jamaneurol.2020.112732275288
   PubMed Web of Science ®Google Scholar
• Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8–12. doi:10.1016/j.jocn.2020.05.01732409215
   PubMed Web of Science ®Google Scholar
• Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413:116832. doi:10.1016/j.jns.2020.11683232299017
   PubMed Web of Science ®Google Scholar
• Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38(7):1549.e3–1549.e7. doi:10.1016/j.ajem.2020.05.024
   Web of Science ®Google Scholar
• Herman C, Mayer K, Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology. 2020;95(2):77–84. doi:10.1212/WNL.000000000000967332345728
   PubMed Web of Science ®Google Scholar
• Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94(19):809–810. doi:10.1212/WNL.000000000000945532229625
   PubMed Web of Science ®Google Scholar
• Payus AO, Liew Sat Lin C, Mohd Noh M, Jeffree MS, Ali RA. SARS-CoV-2 infection of the nervous system: a review of the literature on neurological involvement in novel coronavirus disease (COVID-19). Bosn J Basic Med Sci. 2020. doi:10.17305/bjbms.2020.4860
   Web of Science ®Google Scholar
• Huo L, Xu KL, Wang H. Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic. World J Clin Cases. 2021;9(5):1058–1078. doi:10.12998/wjcc.v9.i5.105833644169
   PubMed Web of Science ®Google Scholar
• Li X, Wang Y, Wang H, Wang Y. SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease. QJM. 2021;114(9):625–635. doi:10.1093/qjmed/hcab15734043803
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Huo L, Li Q, Chen J, Wang H. SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature. J Neurol. 2021;1–22. doi:10.1007/s00415-021-10771-832651671
   PubMed Web of Science ®Google Scholar
• Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 2020;77(8):1028. doi:10.1001/jamaneurol.2020.212532469400
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601–e605. doi:10.1212/WNL.000000000000961932303650
   PubMed Web of Science ®Google Scholar
• Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94(22):959–969. doi:10.1212/WNL.000000000000956632284362
   PubMed Web of Science ®Google Scholar
• Goh Y, Beh D, Makmur A, Somani J, Chan A. Pearls and Oy-sters: facial nerve palsy as a neurological manifestation of Covid-19 infection. Neurology. 2020;95:364–367. doi:10.1212/WNL.000000000000986332439822
   PubMed Web of Science ®Google Scholar
• Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;201187. doi:10.1148/radiol.2020201187
   PubMed Web of Science ®Google Scholar
• Sotoca J, Rodríguez-álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e803. doi:10.1212/NXI.000000000000080332522767
   PubMed Web of Science ®Google Scholar
• Jasti M, Nalleballe K, Dandu V, Onteddu S. A review of pathophysiology and neuropsychiatric manifestations of COVID-19. J Neurol. 2020;268:2007–2012. doi:10.1007/s00415-020-09950-w32494854
   PubMed Web of Science ®Google Scholar
• D’ Onofrio N, Scisciola L, Sardu C, et al. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. Cardiovasc Diabetol. 2021;20(1):99. doi:10.1186/s12933-021-01286-733962629
   PubMed Web of Science ®Google Scholar
• Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9(5):1417. doi:10.3390/jcm9051417
   PubMed Web of Science ®Google Scholar
• Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines. 2020;8(11):462. doi:10.3390/biomedicines8110462
   PubMed Web of Science ®Google Scholar
• Hernández-Fernández F, Valencia HS, Barbella-Aponte RA, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089–3103. doi:10.1093/brain/awaa23932645151
   PubMed Web of Science ®Google Scholar
• Rothstein A, Oldridge O, Schwennesen H, Do D, Cucchiara BL. Acute cerebrovascular events in hospitalized COVID-19 patients. Stroke. 2020;STROKEAHA120030995. doi:10.1161/STROKEAHA.120.030995
   Web of Science ®Google Scholar
• Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020. doi:10.1136/jnnp-2020-323586
   Web of Science ®Google Scholar
• Chougar L, Mathon B, Weiss N, Degos V, Shor N. Atypical deep cerebral vein thrombosis with hemorrhagic venous infarction in a patient positive for COVID-19. AJNR Am J Neuroradiol. 2020. doi:10.3174/ajnr.A6642
   Web of Science ®Google Scholar
• Heman-Ackah SM, Su YS, Spadola M, et al. Neurologically devastating intraparenchymal hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation: a case series. Neurosurgery. 2020;87(2):E147–E151. doi:10.1093/neuros/nyaa19832424429
   PubMed Web of Science ®Google Scholar
• Larson AS, Savastano L, Kadirvel R, Kallmes DF, Hassan AE, Brinjikji W. COVID-19 and the cerebro-cardiovascular systems: what do we know so far. J Am Heart Assoc. 2020;e016793. doi:10.1161/JAHA.120.01679332393136
   PubMed Web of Science ®Google Scholar
• Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. doi:10.1056/NEJMc200978732343504
   PubMed Web of Science ®Google Scholar
• Vu D, Ruggiero M, Choi WS, et al. Three unsuspected CT diagnoses of COVID-19. Emerg Radiol. 2020;27(3):229–232. doi:10.1007/s10140-020-01775-432285222
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with covid-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc200757532268022
   PubMed Web of Science ®Google Scholar
• Fan S, Xiao M, Han F, et al. Neurological manifestations in critically ill patients with COVID-19: a Retrospective Study. Front Neurol. 2020;11:806. doi:10.3389/fneur.2020.0080632754114
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-032192578
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected Pneumonia in Wuhan, China. JAMA. 2020. doi:10.1001/jama.2020.1585
   Web of Science ®Google Scholar
• Chen R, Liang W, Jiang M, et al. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020. doi:10.1016/j.chest.2020.04.010
   Web of Science ®Google Scholar
• Sardu C, D’Onofrio N, Balestrieri ML, et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control. Diabetes Care. 2020;43(7):1408–1415. doi:10.2337/dc20-072332430456
   PubMed Web of Science ®Google Scholar
• Sardu C, Gargiulo G, Esposito G, Paolisso G, Marfella R. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19. Cardiovasc Diabetol. 2020;19(1):76. doi:10.1186/s12933-020-01047-y32527257
   PubMed Web of Science ®Google Scholar
• Sardu C, D’Onofrio N, Balestrieri ML, et al. Hyperglycaemia on admission to hospital and COVID-19. Diabetologia. 2020;63(11):2486–2487. doi:10.1007/s00125-020-05216-232632527
   PubMed Web of Science ®Google Scholar
• Marfella R, Paolisso P, Sardu C, et al. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 2020;46(5):403–405. doi:10.1016/j.diabet.2020.05.00532447102
   PubMed Web of Science ®Google Scholar
• Sardu C, Maggi P, Messina V, et al. Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? data from centers of Southern Italy. J Am Heart Assoc. 2020;9(17):e016948. doi:10.1161/JAHA.120.01694832633594
   PubMed Web of Science ®Google Scholar
• Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116–1120. doi:10.1515/cclm-2020-018832172226
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:10.1007/s00134-020-06062-x32367170
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip M, van der Meer N, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147. doi:10.1016/j.thromres.2020.04.01332291094
   PubMed Web of Science ®Google Scholar
• Garaci F, Di Giuliano F, Picchi E, Da Ros V, Floris R. Venous cerebral thrombosis in COVID-19 patient. J Neurol Sci. 2020;414:116871. doi:10.1016/j.jns.2020.11687132422428
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.01732173574
   PubMed Web of Science ®Google Scholar
• Marfella R, Paolisso P, Sardu C, et al. SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. Crit Care. 2021;25(1):217. doi:10.1186/s13054-021-03643-034167575
   PubMed Web of Science ®Google Scholar
• Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Front Neurol. 2020;11:565. doi:10.3389/fneur.2020.0056532574250
   PubMed Web of Science ®Google Scholar